• News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • X (Twitter)
  • LinkedIn
Stock Screener·US·Healthcare·UNH
Share

UnitedHealth Group Incorporated Stocks

$ 408.34Last Updated 11.06.2026

Issuer Rating

6/7
Performance

Favourable

Risk

Low

Recommendation

Buy

Market Cap

$ 370.03B

$ 408.34
Key Takeaways

Risk factor

Low price volatility

Data is available to registered users only
Data is available to registered users only

Profitability factor

Weak growth

Data is available to registered users only
Data is available to registered users only
Sign up to get free access to key risk and return factors, detailed company valuation, and analyst forecasts
Sign up to access all the key risk and return factors

Latest news

22.04.2026 15:15

Morning in New York: trading will go without sharp movements

28.01.2026 15:30

Morning in New York: Fed signals in focus

28.01.2026 02:14

New S&P 500 record, dollar falls, gold rises. What's on the market before Mag7 reports?

27.01.2026 15:34

Morning in New York: trading will take place in a turbulent zone

27.01.2026 10:58

Insurers' stocks in the U.S. collapsed over plans to keep Medicare payment rates unchanged

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

About

UnitedHealth Group Incorporated, founded in 1977 and based in Minnetonka, Minnesota, operates as a comprehensive healthcare enterprise across the United States. Its multifaceted operations are divided into four primary segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. UnitedHealthcare is dedicated to providing diverse health benefit plans and services, serving a wide array of clients including national and public sector employers, mid-sized and small businesses, and individuals. This segment also delivers specialized health and wellness solutions for those aged 50 and older, manages Medicaid programs and children's health insurance, and extends health, dental, and clinical benefits to state initiatives supporting economically disadvantaged, medically underserved populations, and those without employer-sponsored coverage. Optum Health focuses on direct patient care, comprehensive care management, promoting wellness and consumer engagement, and offering health-related financial services to individual consumers, healthcare providers and systems, employers, payers, and public sector entities. Optum Insight furnishes technology solutions, data intelligence products, strategic advisory consulting, and outsourced managed services for hospital systems, medical practitioners, health plans, governmental agencies, life sciences firms, and other organizations within the healthcare ecosystem. Finally, Optum Rx handles pharmacy benefit management, encompassing retail network contracting, home delivery services, specialty and community health pharmacy operations, drug procurement, and clinical capabilities, while also developing programs for optimizing medication use through step therapy, formulary management, enhancing drug adherence, and comprehensive disease and drug therapy management.

Company Valuation

Fairly valued
4/7

Based on key historical and expected multiples, the stock is fairly valued relative to its peers. Specifically, the stock is fairly valued on P/E, neutral on EV/EBITDA, r

Data is available to registered users only
Sign up to access detailed valuation

Target Price

Somewhat favourable
5/7

The average target price of UNH is 427 and suggests 5% upside potential. Usually, this means a HOLD recommendation among investment firms. This neutral recommendation sug

Data is available to registered users only
Sign up to access analyst forecasts

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

Trending

13.06.2026 01:40

Hope for peace with Iran and SpaceX lifted spirits: stocks rose for second straight day

13.06.2026 01:05

SpaceX shares rose in value by 19% on the first day of trading. Is it worth buying them?

13.06.2026 01:04

SpaceX shares slowed before closing in first trading since record IPO

13.06.2026 00:44

Retail investors bought $15 billion worth of SpaceX stock. Demand was at least 6 times that amount

13.06.2026 00:30

Nebius, AI and space: five new companies will join the Nasdaq-100. Is it too late to buy them?

X-channel

Buy

Sell

0 more stocks

Company

  • About
  • Contributors
  • Contacts
  • Legal Information

Social media

  • X (Twitter)
  • LinkedIn
  • X (Twitter)
  • LinkedIn
Oninvest© 2026